Female Pattern Hair Loss Clinical Trial
Official title:
Minoxidil in Treatment of Androgenetic Alopecia
The study will be included 60 women with FPHL. The diagnosis of FPHL will be established by clinical (Ludwig classification) and trichoscopic evaluation of frontal and occipital regions of the scalp.
Enrolled women will be randomly assigned into 3 treatment groups: group A will apply topical
minoxidil 5% in 90% ethanol and 5% propylene glycol, group B will apply topical minoxidil 5%
in pure ethanol alone and group C will apply pure ethanol (placebo) twice daily.
The treatment will be continued for six months with regular visits at 3 months intervals.
The medications will be provided in bottles which were identical in shape and color, and were
coded by a third party.
Both patients and investigator will be blinded to the medication. Disclosure of the codes
will be done, by a third party, at the end of the study.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00175617 -
Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss
|
Phase 2 | |
| Withdrawn |
NCT02486848 -
Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil
|
N/A | |
| Completed |
NCT00958750 -
Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia
|
Phase 3 | |
| Completed |
NCT02206802 -
Minoxidil Response Testing in Females With Female Pattern Hair Loss
|
||
| Completed |
NCT01900041 -
A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair Loss
|
Phase 2 |